Postdischarge adverse drug reactions in primary care originating from hospital care in France: A nationwide prospective study

Drug Safety

Volumn 24, Issue 10, 2001, Pages 781-792

  Letrilliart, Laurent ^a   Hanslik, Thomas ^b   Biour, Michel ^c   Fagot, Jean Paul ^a   Guiguet, Marguerite ^a   Flahault, Antoine ^a  

^a INSERM   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; CARBAMAZEPINE; CARDIOVASCULAR AGENT; CISPLATIN; CLOMIPRAMINE; CODEINE; CYCLOPHOSPHAMIDE; CYPROTERONE ACETATE; DICLOFENAC; DILTIAZEM; DOXORUBICIN; ENALAPRIL; ETOPOSIDE; FLUINDIONE; FLUOXETINE; FUROSEMIDE; GLIBENCLAMIDE; IRON; METFORMIN; METHYLPREDNISOLONE; MORPHINE; NICERGOLINE; OFLOXACIN; OPIATE DERIVATIVE; PARACETAMOL; PSYCHOTROPIC AGENT; RAMIPRIL; SERTRALINE; SPIRONOLACTONE; ZUCLOPENTHIXOL;

ADULT; AGED; ARTICLE; DRUG INDUCED DISEASE; EDEMA; ELDERLY CARE; FEMALE; FOLLOW UP; FRANCE; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; HYPERKALEMIA; HYPOTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PRESCRIPTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SIDE EFFECT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; AGED; AGED, 80 AND OVER; DATA COLLECTION; FEMALE; FRANCE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS;

EID: 0034840483     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200124100-00006     Document Type: Article

References (52)

1. Incidence of adverse drug reactions in hospitalized patients
2. Iatrogénie médicamenteuse: Estimation de sa prévalence dans les hôpitaux publics français
3. Trends in hospital utilization, 1965-86
4. The frequency of adverse drug reactions as dependent upon age, sex, and duration of hospitalization
5. The necessity and efficiency of wound surveillance after discharge
6. Screening inpatient quality using post-discharge events
7. Computer networking as a tool for public health surveillance: The French experiment
8. Harmonisation in pharmacovigilance
9. Introducing MEDWatch: A new approach to reporting medication and device adverse effects and product problems
10. Imputability of unexpected or toxic drug reactions
11. Evaluation de la iatrogènese médicamenteuse évitable: Méthodologie
12. Adverse biochemical and clinical consequences of furosemide administration
13. Angiooedema and urticaria with angiotensin converting inhibitors
14. The effects of acetylsalicylic acid on swelling, pain and other events after surgery
15. Furosemide withdrawal in elderly heart failure patients with preserved left ventricular systolic function
16. Angiotensin converting enzyme inhibitors and moderate hypertension
17. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia
18. Fluoxetine versus sertraline and paroxetine in major depression: Tolerability and efficacy in anxious depression
19. Clomipramine therapy in the geriatric drug monitoring
20. Randomized trial of postoperative patient-controlled analgesia vs intramuscular narcotics in frail elderly men
21. United Kingdom prospective diabetes study (UKPDS) 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years
22. Codeine and oxycodone use in patients with chronic rheumatic disease pain
23. Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip: A randomised, double-blind, multi-centre study
24. A comparison of ciprofloxacin, norfloxacine, ofloxacine, azithromycin and cefixime examined by observational cohort studies
25. Adverse drug reactions with fluoroquinolones
26. Side effects of iron supplements in blood donors: Superior tolerance of heme iron
27. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung
28. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer
29. Adverse drug reactions: Physicians' opinions versus a causality assessment method
30. Intensive monitoring for adverse drug effects in patients discharged from acute medical wards
31. Under-reporting of adverse drug reactions in general practice
32. Preventability of emergent hospital readmission
33. Drug-related unplanned readmissions to hospital
34. Les pathologies prises en charge à l'hôpital
35. Frequency and cost of serious adverse drug reactions in a department of general medicine
36. Predisposing factors in adverse drug reactions to drug
37. The ambiguous relation between aging and adverse drug reactions
38. The nature of adverse events in hospitalized patients: Results of the Harvard Medical Practice Study II
39. Patient risk factors for adverse drug events in hospitalized patients
40. Influence of hospitalization on drug therapy in the elderly
41. The adverse effects of hospitalization on drug regimens
42. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients
43. Incidence and preventability of adverse drug events in hospitalized adults
44. Incidence of adverse drug events and potential adverse drug events. Implications for prevention
45. Factors associated with preventable adverse drug reactions